Oriental Aromatics Ltd Q2 FY2025 Concall Summary

Key Takeaways

• Margin recovery underway, guidance held: EBITDA margin improved to 12.08% from 10.29% QoQ and 4.8% YoY, but management declined to raise the 10-12% band, citing new-plant stabilization.
• New capacity is live but unproven: Both the Vadodara hydrogenation plant and the Mahad greenfield site have begun commercial production, yet revenue contribution and ramp-up timelines remain vague.
• Demand narrative has turned: Management declared the destocking cycle over in H2 2024 and pointed to healthy RFQ conversations for H1 2025, though camphor pricing stays tricky.
• Camphor is the open risk: The religious-season demand went well, but the off-season could bring pricing negativity, and management offered no forecast.
• What to watch next quarter: Whether the Mahad and Vadodara plants convert positive customer feedback into disclosed commercial sales, and how camphor prices behave in the off-season.

Margin & Guidance

• EBITDA band reiterated: Management kept the 10-12% guidance despite the Q2 jump to 12.08%, because two new plants with new products need time to stabilize and gain customer acceptance.
• Old margins not promised: When asked about returning to ~15% margins given the improved industry scenario, management explicitly declined to commit, saying "I don't want to commit" going forward.
• Inter-division margin fluidity: Because the business is backward-integrated, profitability rearranges internally across divisions when chemical prices move: lower chemical prices improve fragrance/flavor margins, so no single division has a fixed margin rank.
• New-product margin hurdle: Every product selected must meet a basic EBITDA requirement over a longer period, but supplying a basket of products globally makes the company more important to customers and supports profitability in a macro sense.

Bodani: "we would still stay between the guidance that we have given of 10-12% considering the fact that we have 2 new plants that have already been commissioned. So we are going to just stay with the 10-12% for now and going forward, I don't want to commit."

New Capacity: Commissioned but Unquantified

• Vadodara hydrogenation plant: Began production in July 2024 and reached roughly 30% of planned capacity by the third month; commercial sales have started, with substantial interest from global distributors and spot customers.
• Mahad greenfield site: Commenced commercial production on 12 November 2024, dedicated to the specialty aroma ingredient Evermoss; management calls it a significant future growth driver but gave no timeline or volume.
• RFQ customer onboarding: For the hydrogenation plant, onboarding of qualified customers is expected in H2 2025, meaning material revenue contribution is still several quarters away.
• Revenue potential, loosely framed: Management offered a top-down view that Vadodara, Mahad, process reengineering and growth in current products together could add ₹250-300 crores to the top line over the next 2-3 years, but declined to break out near-term incremental revenue when pressed.
• Brownfield vs greenfield math: On a cautious approach, brownfield projects are expected to deliver 1.5-1.7x (roughly ₹150-170 crores) with a 500-day lag, while greenfield projects are seen at 1-1.2x (roughly ₹100-120 crores).
• Commercial sales feedback: Feedback on new products is "pretty positive" and management expects to close commercial sales, but would not quantify because conversations are ongoing.

Satoskar: "I think if you add Vadodara, if you add Mahad, and if you add the process reengineering and the growth that we will experience in our current set of products, I think we shouldn't be surprised to probably see an addition of anywhere between 250 to 300 crores in the next 2-3 years to the top line."

Demand Environment

• Destocking over: Management stated comfortably that the destocking and reduced-demand discussion has come to an end, definitely in H2 2024; fresh orders have started coming back after multiple rounds of H1 2025 demand conversations with RFQ customers, and the numbers look healthy.
• Steady demand expected: Barring global shocks to major economies, steady demand is anticipated for most ingredient products; on the fragrance and flavor side, product launches are now happening at a relatively fast pace after a gap of roughly a year.
• Export growth engine: The fragrance division continues its growth trajectory, driven by new customer acquisitions in India and international markets, healthy growth from existing domestic and international customers, and significant contribution from smaller and regional customers.
• Specialty aroma ingredients: The division recorded double-digit growth in both production and sales on a YoY basis in the first half.

Satoskar: "we can very comfortably say that the whole discussion on destocking and reduced demand probably has come to an end definitely in H2 2024. Going forward, unless there are no global shocks to any of the major economies, I think we will see a steady demand for most of the products that we sell"

Camphor & Terpene Chemicals: The Overhang

• Price pressure persists: Camphor and terpene chemicals continue to be under price pressure for multiple reasons, and camphor in the religious space is a cyclical product.
• Seasonal tailwind, then uncertainty: The religious season went off very well, but demand in the off-season remains to be seen; management will update by the end of next quarter.
• Pricing outlook is opaque: The demand-supply situation on camphor stays tricky, and once into the off-season there could be some level of negativity in pricing; management said it cannot comment exactly on what will happen.
• US market not a camphor driver: The US is not a major consumer of camphor; the company has a sizable position in whatever camphor is sold there in the healthcare space, but any tariff-driven opportunity is purely speculative for now.

Satoskar: "I think it is a market which is governed by demand and supply. Like I said that inherently the demand supply situation on the camphor piece stays a bit tricky and once we get into the off-season you probably would have some level of negativity coming in terms of pricing. So we will have to wait and watch, but I wouldn't be able to comment exactly on what would happen."

Raw Material & Inventory

• Raw material stability: Most raw material prices have been stable or showing signs of marginal price increases; broadly, everything looks stable in terms of inventory, availability and pricing.
• Inventory rationalization complete: The inventory rationalization cycle is largely over, and fresh orders have started coming back.

Guidance & Commitments

Key Metrics